Cargando…
Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series
We repurposed the antifibrotic drug pirfenidone—which is approved for treatment of idiopathic lung fibrosis—in a series of patients with nonalcoholic steatohepatitis-related cirrhosis. Our report demonstrates the observed improvements in necroinflammation and regression of cirrhosis with pirfenidone...
Autores principales: | Philips, Cyriac Abby, Padsalgi, Guruprasad, Ahamed, Rizwan, Paramaguru, Rajaguru, Rajesh, Sasidharan, George, Tom, Mahadevan, Pushpa, Augustine, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132022/ https://www.ncbi.nlm.nih.gov/pubmed/32274350 http://dx.doi.org/10.14218/JCTH.2019.00056 |
Ejemplares similares
-
A Single‐Center Experience on Outcomes of Complementary and Alternative Medicine Use Among Patients With Cirrhosis
por: Philips, Cyriac Abby, et al.
Publicado: (2019) -
Ayurveda Herbal Medicine-induced Liver Cirrhosis
por: Philips, Cyriac A, et al.
Publicado: (2019) -
Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options
por: Philips, Cyriac Abby, et al.
Publicado: (2019) -
Pseudo Symmer’s Pipe-Stem Fibrosis in Idiopathic Noncirrhotic Portal Hypertension Associated with POEMS Syndrome
por: Abby Philips, Cyriac, et al.
Publicado: (2017) -
Metoprolol-induced Severe Liver Injury and Successful Management with Therapeutic Plasma Exchange
por: Philips, Cyriac, et al.
Publicado: (2017)